Vanguard Personalized Indexing Management
RYTM icon

Vanguard Personalized Indexing Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$450K Buy
4,054
+952
+31% +$86.1K ﹤0.01% 1465
2026
Q1 		$270K Buy
3,102
+723
+30% +$70.3K ﹤0.01% 1668
2025
Q4 		$255K Buy
2,379
+311
+15% +$33K ﹤0.01% 1601
2025
Q3 		$209K Buy
+2,068
New +$192K ﹤0.01% 1683

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Personalized Indexing Management's RYTM Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Rhythm Pharmaceuticals (RYTM) stake by 31% in Q2 2026, buying an estimated $86.1K and bringing the position to 4,054 shares worth $450K. The position accounts for ﹤0.01% of the portfolio, ranked #1465.

Vanguard Personalized Indexing Management first reported a position in RYTM in Q3 2025 and has held it in 4 quarters since. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Vanguard Personalized Indexing Management held 4,054 shares of Rhythm Pharmaceuticals worth $450K as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 952 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $86.1K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1465 holding.
  • Vanguard Personalized Indexing Management first reported a position in Rhythm Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.